Eleven Stocks Expected to Rise by 50% to 100% — or More
Daily ETF Folly: Why There Is No True Biotech Representation in ETFs
Top Analyst Upgrades and Downgrades (AL, ALU, AIG, AFL, BUD, ADSK, DRI, DB, DUK, HA, ILMN, IP, ISRG, NWL, NCLH, CRM, SQNM, TEF, V)
Daily Blogwatch: Cold on solar; why are we drinking so much kool-aid?
Sequenom: Mishandling of results delays launch of Down Syndrome tests